Quarterly report [Sections 13 or 15(d)]

Supplemental Condensed Consolidated Balance Sheet Information - Schedule of Accrued Expenses and Other Current Liabilities (Details)

v3.25.3
Supplemental Condensed Consolidated Balance Sheet Information - Schedule of Accrued Expenses and Other Current Liabilities (Details) - USD ($)
Sep. 30, 2025
Dec. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]    
Accrued consulting $ 266,291 $ 202,379
Accrued compensation 2,109,933 999,303
Accrued research and development 1,163,993 1,397,348
Accrued other 116,166 81,000
Total accrued expenses and other current liabilities $ 3,656,383 $ 2,680,030